$0.6599
-0.000100-0.02%
At close: -
$0.6505
-0.00940-1.42%
After Hours: 7:56 PM EDT
Comments
Loading...
Latest Lexicon Pharmaceuticals Stock News | NASDAQ:LXRX | Benzinga
Get the latest news on Lexicon Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Lexicon Pharmaceuticals performance
Categories: All
Wednesday, May 14, 2025
Tuesday, May 13, 2025
Monday, May 12, 2025
Friday, April 25, 2025
Monday, March 31, 2025
Friday, March 28, 2025
- What 6 Analyst Ratings Have To Say About Lexicon Pharmaceuticals
- HC Wainwright & Co. Reiterates Buy on Lexicon...
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected
- Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Lexicon Pharmaceuticals shares are trading hi...
- Lexicon Pharmaceuticals Enters Exclusive Lice...
Friday, March 07, 2025
Thursday, March 06, 2025
Monday, March 03, 2025
- Lexicon Pharmaceuticals shares are trading lo...
- HC Wainwright & Co. Reiterates Buy on Lexicon...
- Needham Reiterates Hold on Lexicon Pharmaceut...
- Lexicon Pharmaceuticals (LXRX) Stock Is Down: What's Going On?
- Lexicon's Phase 2b Study Shows 10 mg Pilavapa...
- Reported Sunday, Lexicon Pharmaceuticals To P...
